Amgen Valuation Overview

AMGN -- USA Stock  

USD 190.52  1.24  0.65%

Amgen shows prevailing Real Value of $186.939 per share. The current price of the firm is $190.52. At this time the firm appears to be fairly valued. Macroaxis approximates value of Amgen from analyzing the firm fundamentals such as Profit Margin of 9.67% and Return On Equity of 9.59% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
 Time Horizon     30 Days    Login   to change
Amgen is rated second in last dividend paid category among related companies. It is rated third in price to sales category among related companies fabricating about  1.07  of Price to Sales per Last Dividend Paid.

Current Market Valuation

Amgen Valuation Boundaries
Fairly Valued
July 20, 2018
Market Value
Real Value
Target Odds
Amgen is not too risky asset. Calculation of real value of Amgen is based on 1 month time horizon. Increasing Amgen time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Coins and Tokens Correlation module to utilize digital token correlation table to build portfolio of cryptocurrencies across multiple exchanges.